Alcohol-Linked Cancer Deaths Double in US
Analysis based on 23 articles · First reported Sep 03, 2026 · Last updated Sep 22, 2026
The study could pressure alcohol beverage companies as public awareness of alcohol's cancer risks grows, potentially leading to reduced consumption and tighter regulations. Conversely, it may benefit healthcare and pharmaceutical sectors focused on cancer screening, treatment, and prevention.
A new study led by researchers at the University of Miami Miller School of Medicine and its Sylvester Comprehensive Cancer Center found that alcohol-attributable cancer deaths in the United States more than doubled between 1990 and 2023, rising from about 11,361 to 23,126 annually. The research, published in The Lancet Regional Health - Americas and presented at the 2025 American Society of Clinical Oncology Annual Meeting, analyzed three decades of Global Burden of Disease data. The study found that alcohol-linked cancers extend beyond liver cancer to include colorectal, breast, esophageal, pancreatic, and prostate cancers. Among adults under 55, colorectal cancer was the leading alcohol-attributable cancer death for men, while breast cancer ranked first for women. The International — International Agency for Research on Cancer classifies alcoholic beverages as Group 1 carcinogens. The United States — Centers for Disease Control and Prevention estimates about 20,000 annual alcohol-related cancer deaths. Researchers including Dr. Chinmay Jani and Dr. Gilberto Lopes emphasized that alcohol is a modifiable risk factor and called for greater public awareness. Geographic differences were noted, with Washington, D.C. having the highest alcohol-attributable cancer death rate and Utah the lowest. The study's limitations include its observational design and reliance on population-level estimates.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard